Gunning Group recognized with Connaught Innovation Award!
The Gunning Group has received a Connaught Innovation Award to support the development of HDAC2 inhibitors for the treatment of Duchenne...
Dunad Therapeutics has struck a new multi-million dollar deal with Novartis
Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to...
Gunning Group receives $100,000 grant from Brain Cancer Canada
A pioneering approach led by Prof. Patrick Gunning at the University of Toronto, leveraging advanced medicinal chemistry to help develop...
Patrick Gunning recognized with Connaught Innovation Award
Professor Patrick Gunning of the department of chemical and physical sciences at the University of Toronto Mississauga has received a...
Our PhD graduate Aaron Cabral to pursue career in drug discovery
iAaron Cabral will earn his PhD in chemistry from the Unversity of Toronto’s Faculty of Arts & Science this week after focusing his...
Murtaza Hassan featured in U of T's Tetris-themed solution to battling Cancer
“Muhammad thought chemistry was boring—but then his love of puzzles led him to develop a Tetris-themed solution to battle cancer at @UTM....
Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8
This latest research was just published in the Journal of Medicinal Chemistry on targeting HDAC8, a protein that is highly associated...
Scientific Breakthrough
Read article in link below! https://www.thefutureisunlimited.ca/scientific-breakthrough/
